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SUMMARY 1 
 B23/nucleophosmin was identified in vitro as a stimulatory factor for 2 
replication of adenovirus (Ad) DNA complexed with viral basic core proteins.  In the 3 
present study, we have studied the in vivo function of B23 in Ad life cycle.  We found 4 
that both the expression of a decoy mutant derived from Ad core protein V that tightly 5 
associates with B23 and siRNA-mediated depletion of B23 impede the production of 6 
progeny virions.  However, B23 depletion did not significantly affect the replication 7 
and transcription of the virus genome.  Chromatin immunoprecipitation analyses 8 
revealed that B23 depletion significantly increases the association of viral DNA with 9 
viral core proteins and cellular histones.  These results suggest that B23 is involved in 10 
the regulation of association and/or dissociation of core proteins and cellular histones 11 
with the virus genome.  In addition, our results suggest that proper viral chromatin 12 
assembly regulated in part by B23 is crucial for the maturation of infectious virus 13 
particles. 14 
15 
 3 
INTRODUCTION 1 
Adenovirus (Ad) is an icosahedral particle with linear double-stranded DNA of 2 
approximately 36,000 base pairs in length.  The linear DNA is covalently linked with 3 
virally coded terminal proteins and condensed with viral basic proteins Mu, VII, and 4 
V, thus forming a chromatin-like structure termed Ad core/Ad chromatin (Anderson 5 
et al., 1989; Black & Center, 1979; Chatterjee et al., 1985).  Protein VII, a 19 kDa 6 
basic protein, is the major component of Ad core and most tightly associated with the 7 
Ad genome (Sung et al., 1983).  Protein V associates loosely with Ad DNA and forms 8 
an outer shell around Ad core to link it with the capsid through a dimer of polypeptide 9 
VI (Brown et al., 1975; Chatterjee et al., 1985; Fedor & Daniell, 1983).  The virus 10 
genome is thought to be packed around the hexamer of core protein VII, and each unit 11 
of viral DNA-VII hexamer complex is bridged by core protein V (Dery et al., 1985; 12 
Sung et al., 1977).   13 
Infecting virus particles are disassembled in the cytoplasm stepwise after 14 
penetration through endocytosis, and Ad core enters into the nucleus through nuclear 15 
pore complexes (Greber et al., 1996; Martin-Fernandez et al., 2004; Nakano et al., 16 
2000; Trotman et al., 2001).  During entry of the virus genome into the nucleus, core 17 
protein V seems to be dissociated from viral chromatin.  Thus, viral DNA associated 18 
with core protein VII functions as a template for viral early gene transcription and 19 
DNA replication in the infected cell nucleus (Chatterjee et al., 1986; Haruki et al., 20 
2006; Xue et al., 2005).  However, it was reported that core proteins function as a 21 
repressor for transcription and replication in vitro (Johnson et al., 2004; Matsumoto et 22 
al., 1995; Nakanishi et al., 1986).  Therefore, it is suggested that core proteins are 23 
either released or remodeled after entry into the host nucleus (Chen et al., 2007; 24 
Matsumoto et al., 1993; Matsumoto et al., 1995; Spector, 2007).  Histones may 25 
 4 
associate with incoming viral DNA (Sergeant et al., 1979; Tate & Philipson, 1979).  1 
Recently, it has been shown that not only protein VII but also cellular histones are 2 
functional components of viral chromatin in early phases of infection (Komatsu et al., 3 
2011).  During late stages of infection, the precursor of core protein VII (pre-VII) and 4 
core protein V are synthesized at high levels concomitantly with viral DNA synthesis, 5 
assembled onto newly replicated DNA, and incorporated into immature virions 6 
(Daniell et al., 1981).  Newly replicated viral DNA may associate with cellular 7 
histones (Dery et al., 1985).  However, mature Ad particles do not contain cellular 8 
histones.  It is still largely unknown how only the virus genome associated with viral 9 
core proteins is selectively incorporated into virions.  It is also unknown which 10 
cellular factors are involved in this process.  11 
Previously, we identified host factors termed Template Activating Factors 12 
(TAF)-I, -II, and -III from uninfected HeLa cell extracts that remodel the Ad core 13 
structure and stimulate replication and transcription from Ad core (Matsumoto et al., 14 
1993; Matsumoto et al., 1995; Okuwaki et al., 2001a).  Recently, we have shown that 15 
TAF-I remodels the Ad core structure by forming a ternary complex with Ad DNA-16 
core protein VII complexes and plays an important role in early stages of the Ad 17 
infection cycle (Gyurcsik et al., 2006; Haruki et al., 2003; Haruki et al., 2006; 18 
Komatsu et al., 2011).  TAF-II is identical to nucleosome assembly protein-1 (NAP-19 
1), a structural and functional homologue of TAF-I (Kawase et al., 1996; Nagata et al., 20 
1995).  The major component of TAF-III was found to be B23/nucleophosmin 21 
(Okuwaki et al., 2001a).  22 
 B23/nucleophosmin is an abundant ubiquitously expressed cellular protein 23 
that modulates diverse molecular functions such as ribosome biogenesis (Hingorani et 24 
al., 2000; Savkur & Olson, 1998), centrosome duplication (Okuda et al., 2000), 25 
 5 
chromatin assembly/disassembly (Okuwaki et al., 2005; Okuwaki et al., 2001b), and 1 
nucleo-cytoplasmic trafficking (Adachi et al., 1993; Yu et al., 2006).  Two splicing 2 
variants of B23, B23.1 and B23.2, which differ only in their C-terminal regions, are 3 
expressed in a variety of growing cells.  Both B23.1 and B23.2 contain highly acidic 4 
domains, while the C-terminal region unique for B23.1 is essential for its RNA 5 
binding activity.  Recently, we have shown that B23 interacts with Ad core protein V, 6 
VII, and pre-VII, and may have a role as chaperone in the assembly of core proteins 7 
into Ad core (Samad et al., 2007).  However, an in vivo role(s) of B23 in the Ad life 8 
cycle has not been clarified yet.  Here, we developed a decoy molecule for the 9 
interaction between B23 and core protein V based on the analysis of their interaction 10 
domains.  Furthermore, we studied the effect of siRNA-mediated knock down (KD) 11 
of B23 on Ad proliferation.  Perturbation of the B23 function either by over-12 
expression of the decoy molecule or KD was shown to impede the Ad proliferation 13 
without significant inhibition of viral DNA replication or viral late gene expression.  14 
However, ChIP experiments indicated that the association of both core proteins and 15 
cellular histones with viral DNA was significantly increased upon B23 KD.  16 
Altogether, the results suggest that B23 is required for maintenance of the proper 17 
adenovirus chromatin structure. 18 
19 
 6 
RESULTS 1 
Domains of core protein V required for its interaction with B23   2 
Recently, we have shown that B23 interacts with Ad core proteins V and VII 3 
(Samad et al., 2007).  However, the function of B23 in Ad proliferation has not yet 4 
been clarified.  To gain additional insight into the in vivo function of B23, we have 5 
designed a decoy molecule based on the analyses of interaction domains between B23 6 
and core protein V.  First, we determined the domain of core protein V required for 7 
the interaction with B23.  Core protein V contains lysine- and arginine-rich basic 8 
clusters in its N- and C- terminal regions.  We have postulated that core protein V 9 
interacts with B23 through these basic clusters, as it has been shown that the acidic 10 
region of B23 is essential for its function (Okuwaki et al., 2001a).  To test this 11 
hypothesis, we constructed a series of deletion mutants as shown in Fig. 1A.  GFP- 12 
and Flag-tagged core protein V mutants were co-expressed with HA-tagged B23.1 in 13 
293T cells, and immunoprecipitation assays were carried out with anti-Flag antibody.  14 
HA-B23.1 was co-immunoprecipitated with full length core protein V (Fig. 1B, lane 15 
10).  The mutants, V(1-313) and V(44-369), lacking the C- and N-terminal regions, 16 
respectively, similarly bound to HA-B23.1 (Fig. 1B, lanes 11 and 12).  However, the 17 
mutants, V(44-313) and V(79-313), lacking both N- and C-terminal basic clusters 18 
showed virtually no ability to interact with HA-B23.1 (lanes 13 and 14).  In contrast, 19 
the N- and C-terminal fragments, V(1-78) and V(314-369), respectively, efficiently 20 
co-precipitated HA-B23.1 (lanes 15 and 16).  These results indicate that both N- and 21 
C-terminal regions are involved in the interaction between B23 and protein V, and 22 
these fragments are good candidates for decoy molecules for its interaction with B23. 23 
 24 
Inhibition of infective virus production by B23 decoy molecule 25 
 7 
We hypothesized that over-expression of these domains would interfere with 1 
the function of B23 in Ad proliferation if B23 is involved in Ad life cycle.  To test 2 
this, HeLa cells were transfected with either GFP-empty vector or vectors for the 3 
expression of GFP-V, GFP-V(1-78), GFP-V(79-313), and GFP-V(314-369), and 4 
super-infected with HAdV5 at 20 hours after transfection.  At 24 hpi, progeny virus 5 
particles were collected, and the infectivity titer was examined as described in 6 
Methods (Supplemental Fig. 1 and Fig. 1).  Results demonstrate that the over-7 
expression of GFP-core protein V, GFP-V(1-78), and GFP-V(314-369), but neither 8 
GFP alone nor GFP-V(79-313), inhibited the production of infectious virus particles.  9 
These results suggest that the mutant proteins that tightly associate with B23 inhibit 10 
the infectious virus production.  It was further demonstrated that the co-expression of 11 
exogenous B23 with GFP-V(1-78) (Fig. 1D) rescued the negative effect of GFP-V(1-12 
78).  These results support the idea that V(1-78) functions as a sort of decoy for the 13 
interaction between B23 and core protein V, and the impairment of this interaction 14 
decreases the progeny virus production level. 15 
 16 
B23 knock-down (KD) inhibits the production of infective viral particle 17 
To further show that B23 is involved in Ad proliferation, we decreased the 18 
cellular B23 level using siRNA specific for B23.1.  Although both B23.1 and B23.2 19 
have been suggested to be differentially involved in Ad replication (Hindley et al., 20 
2007), we focused on B23.1 as it is concentrated in the nucleoli in which core protein 21 
V is located at the late stage of infection (Matthews, 2001), while B23.2 is distributed 22 
throughout the nuclei.  In addition, the depletion of B23.1 alone efficiently decreased 23 
the nucleolar function of B23 (Murano et al., 2008).  Treatment of HeLa cells with 24 
B23.1 siRNA decreased the cellular B23.1 protein level but not β-actin, whereas 25 
 8 
control siRNA had no effect (Fig. 2A).  The expression level of nucleolar proteins 1 
such as nucleolin and fibrillarin were found to be unchanged upon B23 knock down 2 
(KD) (Fig. 2B).  To examine the effect of B23 KD on Ad proliferation, control 3 
siRNA- and B23 siRNA-treated HeLa cells were infected with HAdV5.  We first 4 
examined the effect of siRNA treatment on the localization of viral proteins (Fig. 2C).  5 
In control siRNA-treated cells, DBP was concentrated in nuclear foci and core protein 6 
VII distributed throughout nuclei at 24 hpi.  As previously reported (Hindley et al., 7 
2007; Matthews, 2001), the nucleolar localization of B23 was slightly suppressed 8 
upon Ad infection, and B23 was partially co-localized with core protein VII but not 9 
with DBP.  We also demonstrated that the localization patterns of DBP and core 10 
protein VII were not significantly affected by B23.1 siRNA treatment.  At 24 hpi, the 11 
supernatant fraction containing progeny virus particles were collected, cleared by low 12 
speed centrifugation, and then examined for the infectious titer (Fig.2D).  The 13 
production of infectious progeny virus particles from B23 KD cells were decreased to 14 
approximately 50 to 60% of that from control siRNA-treated cells (Fig. 2D, lanes 1 15 
and 2).  Even under the decreased B23.1 level, Ad virus production was increased 16 
until 48 hpi, although the amounts of produced infective virus during 24-36 hpi were 17 
lower than those of control siRNA-treated cells (Fig. 2C and supplemental Fig. 2).  18 
This result suggests that B23.1 is not essential but plays a crucial role in Ad virus 19 
production, and/or other cellular factor(s) could also be involved (see Discussion).  20 
Next, we investigated whether the effect of B23 KD on Ad virus production could be 21 
rescued by B23 over-expression.  At 36 hours after introduction of control or B23 22 
siRNA, cells were transfected with either empty vector or vector encoding HA-B23.1.  23 
Cells were then infected with Ad at 24 hours after transfection of plasmid DNA, and 24 
the production of progeny virus particles was examined.  The expression level of 25 
 9 
exogenous HA-B23.1 is shown in Fig. 2F.  Over-expression of B23.1 in control cells 1 
slightly inhibited the infectious progeny virus production (Fig. 2D), although this 2 
result was not statistically significant.  Importantly, the exogenous expression of 3 
B23.1 counteracted the negative effect of B23 siRNA-mediated KD on the progeny 4 
virus production.  These results support the idea that B23.1 plays an important role in 5 
the production of infectious virus particles. 6 
 7 
B23 KD has no significant effect on viral DNA replication and late gene 8 
expression 9 
Given that B23 KD decreased the production of infectious virus particles, it was 10 
highly expected that this inhibition might be due to the interference with viral DNA 11 
replication.  To test this notion, control or B23 siRNA-treated HeLa cells were 12 
infected with Ad and the amplification of viral DNA at 12, 18, and 24 hpi was 13 
examined by quantitative PCR using a primer set specific for Ad DNA (Fig. 3A).  14 
Because the amount of Ad DNA was increased as a function of incubation periods 15 
after infection and the amplification of DNA is strongly inhibited by hydroxyl urea 16 
(HU), it is confirmed that the PCR products detected under the condition employed 17 
here correspond to the amounts of the viral DNA.  Surprisingly, no significant 18 
decrease in the amount of viral DNA upon B23 KD was observed (Fig. 3A).  We also 19 
examined the effect of B23 KD on the late gene expression.  The expression level of 20 
the late gene was examined by western blotting with anti-pVII and anti-V antibodies 21 
(Fig. 3B) and RT-PCR with primer sets for mRNAs of the major late promoter and 22 
pVII (Figs. 3C and D).  Consistent with the fact that the late gene transcription 23 
depends on viral DNA replication, the expression level of late genes was strongly 24 
inhibited by the presence of HU.  We did not find any significant decrease in both 25 
 10 
mRNA and core proteins expression levels upon B23 KD (Figs. 3B-D).  These results 1 
indicated that B23 plays a crucial role(s) in progeny virus production at a step(s) later 2 
than virus genome DNA replication and mRNA synthesis.  Since Ad genome 3 
replication completely depends on viral early gene products, we could exclude the 4 
possibility that B23 is involved in the early gene transcription. 5 
 6 
B23 regulates the amounts of core proteins and cellular histones on the Ad 7 
genome   8 
Our biochemical data suggested that the Ad core proteins forms aggregates with 9 
viral DNA when mixed directly, and B23 dissociates the aggregation between DNA 10 
and core proteins (Samad et al., 2007).  In addition, we demonstrated that B23, as a 11 
histone chaperone, regulates the histone density around the rRNA gene region in 12 
uninfected cells (Hisaoka et al., 2010).  Therefore, it is possible that B23 KD affects 13 
the virus genome chromatin structure in infected cells.  To test this possibility, we 14 
examined whether B23 is associated with the virus genome in infected cells.  HeLa 15 
cells were infected with Ad, and at 20 hpi cells were cross-linked with formaldehyde 16 
and then sonicated to release chromatin.  The average size of DNA purified from 17 
chromatin fragments was <1 kb (data not shown).  The extracts were subjected to 18 
immunoprecipitation with antibodies against core proteins V, VII, or B23.  We found 19 
that B23 associates with the virus genome (the VA gene region) as do core proteins V 20 
and VII (Fig. 4A).  We examined the association of B23 with the virus genome using 21 
primer sets as shown in the bottom panel of Fig. 4B.  Next, we assessed the amounts 22 
of core proteins and cellular histones on the virus genome with ChIP assays using 23 
cells treated with control and B23 siRNAs.  HeLa cells treated with siRNAs were 24 
infected with HAdV5 at an MOI of 10.  At 20 hpi, cells were subjected to ChIP assays 25 
 11 
as described above.  Five different primer sets as shown in Fig. 4B were used to 1 
examine the amounts of core proteins and histones on the Ad genome.  In B23 KD 2 
cells, the association of both core proteins V and VII with viral DNA were found to 3 
be increased in all regions tested (Figs. 4C and D).  We also found that the association 4 
of histone H3 along the virus genome is increased (Fig. 4E).   5 
We also examined whether the amounts of core proteins and histone H3 on the 6 
virus genome increased by B23.1 KD were counteracted by exogenously expressed 7 
B23.1.  HeLa cells treated with control or B23.1 siRNA were transiently transfected 8 
with empty and HA-B23.1 expression vectors, and then infected with Ad.  At 24 9 
hours after Ad infection, ChIP assays were carried out as shown in Figure 4 using 10 
primer sets specific for VA gene region (Figure 5).  Western blotting analyses 11 
demonstrated that the amount of B23.1 was decreased efficiently by siRNA treatment, 12 
and that was recovered by transient expression of exogenous HA-tagged B23.1 13 
(Figure 5A, lanes 5 and 6).  Consistent with the data in Figure 4, the amounts of core 14 
proteins V, VII, and histone H3 on the virus genome was increased by B23.1 KD 15 
(Figure 5B-D).  However, those were decreased upon over-expression of HA-B23.1.  16 
Interestingly, even in control siRNA-treated cells, HA-B23.1 over-expression 17 
decreased the association level of core protein V and histone H3.  Taken together, 18 
these results suggest that B23 is involved in the regulation of viral chromatin 19 
formation in infected cells by restricting the access of core proteins and cellular 20 
histones.  21 
22 
 12 
DISCUSSION 1 
 In this paper, we have studied the in vivo function of B23 in Ad life cycle.  2 
Based on previous reports, it was expected that B23 may be involved in Ad DNA 3 
replication (Hindley et al., 2007; Okuwaki et al., 2001a).  However, we could not 4 
detect any significant decrease in the amount of viral DNA (Fig. 3A) as well as the 5 
level of both transcription and translation of core proteins (Figs. 3B-D) upon B23.1 6 
KD.  Therefore, it is possible that B23.1 is not involved in Ad DNA replication in 7 
infected cells under the conditions employed here or the loss of B23.1 may be 8 
compensated alternatively.  In this sense, it is noted that not only B23 but also other 9 
histone chaperones are identified as factors for Ad DNA replication (Kawase et al., 10 
1996; Matsumoto et al., 1993; Okuwaki et al., 2001a).  In addition, we could not 11 
exclude the possibility that B23.2 remained in B23.1 KD cells plays a compensatory 12 
role in Ad DNA replication.  Nevertheless, the data presented here demonstrate that 13 
B23.1 KD did not significantly affect DNA replication and transcription.   14 
We have shown that the decrease of B23 reduces the production of progeny 15 
virions and increases the association level of viral core proteins and cellular histones 16 
on the progeny virus genome DNA.  Based on these observations, we would propose 17 
that (1) B23 is involved in the adenovirus infection cycle at a step later than late gene 18 
expression, and (2) proper virus chromatin assembly is required for the Ad virion 19 
maturation.  The precise mechanism of how B23 regulates viral chromatin and is 20 
involved in the final maturation step of infective virus particles remains unclear.  It is 21 
also possible that in addition to B23, other cellular factor(s) is involved in these 22 
processes.  TAF-I is a candidate of such additional factors, because we have reported 23 
that TAF-I is also associated with pre-VII in the late phases of infection (Gyurcsik et 24 
al., 2006).  It is suspected that the viral DNA associated with appropriate amounts of 25 
 13 
basic proteins is important for encapsidation.  In fact, the Ad genome DNA is 1 
condensed into a core structure only by viral basic proteins within virons, although 2 
viral DNA is associated with histones throughout the infection cycle (Dery et al., 3 
1985; Levy & Noll, 1981).  Thus, it is likely that those virus genomes associated with 4 
cellular histones are restricted and eliminated for encapsidation.  For efficient 5 
encapsidation to occur, cellular histones must be replaced with viral basic proteins 6 
through an unknown pathway.   7 
Newly replicated DNA is associated with histones, and this viral DNA-histone 8 
complex might be important for ongoing replication and transcription throughout the 9 
infection cycle.  At later stages of infection, the synthesis of cellular DNA and 10 
histones is inhibited with the concomitant accumulation of a large pool of viral basic 11 
proteins.  The virus genomic DNA associated with viral core proteins might become 12 
prominent through direct interaction of ongoing replicated DNA with viral basic 13 
proteins and/or replacement of histones on the replicated DNA with viral basic 14 
proteins.  Based on these observations, B23 may be involved in the final 15 
encapsidation step either by replacing histones with core proteins or by restricting the 16 
access of excessive amounts of viral basic proteins/histones to viral DNA.  These 17 
models are in agreement with earlier assumption (Dery et al., 1985; Komatsu et al., 18 
2011).   19 
20 
 14 
METHODS 1 
Cell culture and viruses   2 
HeLa cells were maintained in minimal essential medium (MEM; Nissui) 3 
supplemented with 10% fetal bovine serum (FBS) at 37°C.  293T cells were cultured 4 
at 37°C in Dulbecco’s modified Eagle medium (DMEM; Nissui) containing 10% FBS.  5 
Human adenovirus type 5 (HAdV5) used in this study was amplified and purified as 6 
previously described (Haruki et al., 2006). 7 
 8 
Plasmid construction and transfection  9 
Construction of plasmids for a series of protein V mutants is described in 10 
Supplemental Methods.  pCHA-B23.1 was prepared as described (Okuwaki et al., 11 
2002).  Transient transfection of each plasmid was performed by the calcium 12 
phosphate precipitation method into 293T cells and by Gene-Juice (Novagen) into 13 
HeLa cells. 14 
 15 
Antibodies  16 
The antibodies used in this study were as follows: mouse monoclonal antibody for 17 
B23 that recognizes endogenous B23.1 was purchased from Invitrogen.  Polyclonal 18 
antibody that recognizes both B23.1 and B23.2 was generated in rabbits using 19 
B23ΔC2 expressed in E. coli (Okuwaki et al., 2001a) as an antigen.  Rabbit anti-core 20 
protein V and mouse anti-DBP antibodies were obtained from Dr. W.C. Russel as 21 
generous donation.  Rat polyclonal anti-pre-VII (Haruki et al., 2003), mouse 22 
monoclonal antibody for Flag-tag, rabbit monoclonal antibody for hemagglutinnin 23 
(HA)-tag, rabbit polyclonal antibody for histone H3, and mouse monoclonal antibody 24 
for β-actin were described elsewhere (Murano et al., 2008). 25 
 15 
 1 
Immunoprecipitation assays 2 
293T cells transiently transfected with plasmids where indicated were lysed in 1 ml of 3 
IP buffer (50 mM Tris-HCl,  pH7.9, 1 mM PMSF, 0.1% Triton X-100,  and 1 mg/ml 4 
bovine serum albumin) containing 150 mM NaCl  on ice for 10 min followed by 5 
extensive sonication.  Cell extracts recovered by centrifugation were mixed with anti-6 
Flag antibody, and incubated at 4°C for 3 hours.  Then, protein A sepharose beads (10 7 
µl of resin; GE health care) were added and further incubated for 1 hour with gentle 8 
agitation.  The beads were washed three times with 0.5 ml of IP buffer.  9 
Immunoprecipitated proteins were eluted by an SDS sample buffer, boiled, separated 10 
on a 12.5% SDS-PAGE, and transferred to a polyvinylidene difluoride (PVDF) 11 
membrane (Millipore).  The membrane was subjected to western blotting analysis 12 
using anti-HA antibody.   13 
 14 
Decoy assays 15 
HeLa cells were transfected with either GFP-empty vector or the vector for the 16 
expression of GFP-V(1-78).  At 20 hours post transfection, cells were super-infected 17 
with HAd5 at an MOI of 10.  At 24 hpi, culture supernatant (5 µl) clarified by low 18 
speed centrifugation was used for infection of HeLa cells seeded on coverslips in 12 19 
well-plates (1×105 cells/well) to determine the virus titer.  After incubation for 1 hour, 20 
cells were supplemented with MEM containing 2% FBS and maintained at 37°C in a 21 
5% CO2 environment for additional 15 hours.  Cells on cover slips were collected, 22 
washed with PBS (-), fixed with 3% paraformaldehyde for 10 min at room 23 
temperature, and stained with anti-DBP antibody.  Cells were also counter-stained 24 
with 4',6-diamidino-2-phenylindole (DAPI) and the infectious titers (% of infected 25 
 16 
cells) was determined by counting DBP positive cells out of DAPI positive cells.  1 
This assay was carried out in doublet, and error bars indicate SD.  2 
 3 
B23 knock down by siRNA  4 
B23 Stealth RNAi (NPM1-HSS143154) and Stealth RNAi negative control (catalog 5 
no. 12935-200) were purchased from Invitrogen and introduced into HeLa cells with 6 
Lipofectamine TM RNAiMAX (Invitrogen) according to the manufacturer’s protocol.  7 
At 24 hours post transfection, the medium was replaced, and cells were harvested 8 
after 60 hours post siRNA transfection.  Total HeLa cell lysates were prepared, and 9 
proteins were separated through 10% SDS-PAGE and detected by western blotting.  10 
To examine the effect of B23 KD on the virus production, control and B23 siRNA-11 
treated HeLa cells at 60 hours post transfection were infected with HAdV5 at an MOI 12 
of 10.  After 24 hours, the culture medium was recovered and examined for virus titer 13 
as described above.  14 
 15 
Immunnofluorescence assay 16 
Indirect immunofluorescence assays were carried out essentially as described 17 
previously (Haruki et al., 2006).  Briefly, cells grown on cover slips (15 mm; 18 
Matsunami) were fixed with 4% paraformaldehyde in PBS for 10 min at room 19 
temperature (RT) and then treated with 0.5% NP-40 in PBS for 5 min at RT.  After 20 
blocking with 5% nonfat milk in TBS-T, samples were subjected to 21 
immunofluorescence analyses using antibodies described above.  Localization of the 22 
protein was visualized with the secondary antibodies (anti-rabbit IgG conjugated with 23 
AlexaFluor 488, anti-mouse IgG conjugated with AlexaFluor 568, and anti-rat IgG 24 
conjugated with AlexaFluor 568; Invitrogen).  DNA was visualized by staining with 25 
 17 
TO-PRO-3 iodide (Invitrogen).  Labeled cells were observed with confocal laser 1 
scanning microscopy (LSM5 Exciter; Carl Zeiss) using argon laser (488 nm) and 2 
He/Ne laser (546 and 633 mm) lines. 3 
 4 
Quantitative PCR 5 
Control and B23 siRNA-treated HeLa cells were infected with HAdV5 at an MOI of 6 
10.  At 12, 18, and 24 hours post infection, cells (1×105) were collected and 7 
suspended in lysis buffer (20 mM Tris pH7.9, 100 mM NaCl, 5 mM EDTA, and 0.5% 8 
SDS), and total DNA was purified with proteinase K treatment at 50°C for overnight 9 
followed by phenol-chloroform extraction and ethanol precipitation.  The amount of 10 
DNA was then examined by quantitative (q) PCR with a primer set specific for the Ad 11 
VA gene region (see below).  Total RNA was purified from infected cells (1×105) 12 
using RNeasy mini kit (QIAGEN), and the purified RNA was treated with DNase I 13 
according to the manufacturer’s protocol.  The concentration of RNA in each sample 14 
was determined by using NanoDrop (Thermo Scientific).  cDNA was synthesized 15 
from total RNA (1 µg) using ReverTraAce (Toyobo) and oligo-dT as primer 16 
according to the manufacturer’s protocol.  qPCR with FastStart SYBER Green Master 17 
Mix (Roche) and Thermal Cycler Dice Real Time System (Takara) was performed 18 
using synthesized cDNA as a template with primer sets specific for the mRNA from 19 
major late promoter (MLP), 5’-ACTCTCTTCCGCATCGCTGT-3’ and 5’-20 
GTGACTGGTTAGACGCCT-TTCT-3’, and β-actin gene, 5’-21 
ATGGGTCAGAAGGATTCCTATGT-3’ and 5’-GGTCATCTTCTCGCGGTT-3’. 22 
 23 
ChIP assays 24 
 18 
ChIP assays were carried out according to the manual of ChIP assay kit (Millipore) 1 
with anti-core protein V, pVII, B23, and histone H3 antibodies.  The amount of 2 
immunoprecipitated DNA was determined by qPCR as described above.  The reaction 3 
condition was described previously (Komatsu et al., 2011).  The following primer sets 4 
were used; 5’-GGGTCAAAGTTGGCGTTTTA-3’ and 5’-5 
CAAAATGGCTAGGAGGTGGA-3’ for the E1a promoter region, 5’-6 
GCGGTCCTCCTCGTATAGAA-3’ and 5’-CCCACCCCCTTTTATAGCC-3’ for the 7 
ML promoter region, 5’-GCTGGAGCAAAACCCAAATA-3’ and 5’-8 
TATCTTGCGGG-CGTAAAACT-3’ for the VA region, 5’-9 
GTGTAGACACTTAAGCTCGCCTT-3’ and CTTCAAACTGCCTGACCAAGT-3’ 10 
for the E2A (DBP) region, and 5’-TGGCGTGGTCAAACTCTACA-3’ and 5’-11 
GATTTTTACAATGGCCGGACT-3’ for the E4 ORF region. 12 
13 
 19 
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FIGURE LEGENDS 1 
FIG. 1.  N- and C-terminal regions of core protein V are required for the 2 
interaction with B23.  (A) Schematic diagram of wild type and mutant protein V.  3 
GFP-Flag-tag was fused at the N-termini of core protein V and its mutant proteins.  4 
The basic clusters of core protein V are indicated by filled boxes.  (B) 5 
Immunoprecipitation of Flag-core protein V.  293T cells were transiently co-6 
transfected with HA-B23.1 and either GFP-Flag-V or its mutants.  After 7 
immunoprecipitation without (-) or with (+) anti-Flag antibody, proteins in input 8 
extracts (lanes 1-8) and precipitated proteins (lanes 9-16) were separated through a 9 
12.5% SDS-PAGE and detected by western blotting with anti-HA and anti-Flag (top 10 
and bottom panels, respectively) antibodies.  Positions of GFP-Flag-tagged protein V 11 
and its mutants are indicated by arrow heads at the left side of each lane.  (C) 12 
Inhibition of virion production by a decoy molecule.  HeLa cells were transfected 13 
with either GFP-empty vector or a vector expressing GFP-Flag-tagged V(1-78) 14 
mutant.  At 20 hours after transfection, cells were infected with HAd5.  At 24 hpi, 15 
viruses in the culture fluid were collected and examined for virus titer.  In the bottom 16 
panel, expression of exogenous proteins as well as β-actin was confirmed by western 17 
blotting.  (D) Rescue experiments.  Cells expressing either GFP-Flag (lane 1), GFP-18 
Flag-V(1-78) with pCHA empty vector (lane 2), or GFP-Flag-V(1-78) with pCHA-19 
B23.1 vector (lane 3).  At 24 hour after transfection, cells were super-infected with 20 
Ad and virus production was examined by the procedure as described in (C).  21 
Exogenously expressed proteins were detected by western blotting as shown at the 22 
bottom of the panel.   23 
 24 
 24 
FIG. 2.  B23 is involved in Ad proliferation.  (A) Knockdown (KD) of B23.1.  1 
HeLa cells were transfected with control siRNA (lane 4) or B23 siRNA (lane 5), and 2 
the expression level of B23 was examined by western blotting with anti-B23 antibody.  3 
HeLa cell lysates from 5×103, 1.5×104, and 5×104 cells for lanes 1, 2, and 3, 4 
respectively, were loaded on the same gel and used as standards.   β-actin is shown as 5 
a loading control.  (B) Expression of nucleolar proteins.  The expression level of 6 
indicated proteins was determined by western blotting using HeLa cells treated with 7 
control siRNA or B23.1 siRNA (lanes 1 and 2, respectively) as in (A).  (C) 8 
Localization of viral proteins in B23.1 siRNA-treated cells.  HeLa cells treated with 9 
control- or B23.1-siRNA as indicated at the top of the panels were super-infected with 10 
Ad and subjected to indirect immunofluorescence analyses at 24 hpi.  B23 and DBP 11 
(top panels) or B23 and core protein VII (bottom panels) were simultaneously stained 12 
and visualized.  DNA was counter-stained with To-Pro-3.  (D) Inhibition of infectious 13 
virus production by KD of B23.  HeLa cells treated with either control- or B23.1-14 
siRNA were infected with HAd5.  At 24 hpi, virus titers in the culture medium were 15 
examined as described in Methods (lanes 1 and 2).  At 36 hrs after siRNA transfection, 16 
pCHA empty vector (lanes 3 and 4) or pCHA-B23.1 (lanes 5 and 6) were transfected 17 
and incubated for 24 hrs.  Then, cells were super-infected with HAd5, and the virus 18 
infectivity was determined at 24 hpi as described above.  Experiments were carried 19 
out in triplicate, and error bars indicate standard deviations (SD).  Statistical P values 20 
are indicated at the top of the graph.  (E) Expression level of endogenous and 21 
exogenous B23.  Lysates prepared as indicated in (D) were analyzed by western 22 
blotting with anti-B23.1 and anti β-actin antibodies (top and bottom panels, 23 
respectively). 24 
 25 
 25 
FIG. 3.  Effect of B23 KD on Ad DNA replication and late gene expression.  (A) 1 
Effect of B23.1 KD on Ad DNA replication.  Control or B23.1 siRNA-treated HeLa 2 
cells (black and white bars, respectively) were infected with Ad and incubated 3 
without (-) or with (+) 2 mM hydroxyl urea (HU) as indicated at the bottom of the 4 
panel.  At 12, 18, and 24 hpi, DNA was purified from infected cells, and the amount 5 
of viral DNA was examined by quantitative PCR using a primer set specific for the 6 
VA region of the Ad genome.  Genomic DNA purified from HeLa cells infected with 7 
Ad was used as standards for the amount of the Ad genome in infected cells, and the 8 
relative amounts of Ad DNA was normalized by that of β-actin gene.  (B) Expression 9 
level of late gene products.  Lysates were prepared from infected HeLa cells as 10 
described in (A) at 24 hpi.  Proteins were separated on SDS-PAGE, and analyzed by 11 
western blotting with anti-β-actin, -B23, -core protein V, and -pVII antibodies.  (C, D) 12 
Expression level of Ad late genes.  HeLa cells treated with siRNA as described in A 13 
were infected with Ad.  Total RNA was prepared at 18 hpi, and the expression level 14 
of MLP mRNA (C) and pVII mRNA (D) was determined by quantitative RT-PCR 15 
using specific primer sets as described in Methods.  PCR reactions were performed in 16 
triplicate, and error bars indicate SD.  Three independent experiments showed similar 17 
results. 18 
 19 
FIG. 4.  Effect of B23 KD on the Ad viral chromatin structure.  (A) ChIP assays 20 
were carried out with extracts prepared from Ad-infected HeLa cells at 20 hpi.  DNA 21 
immunoprecipitated without (lane 2) or with anti-pVII, anti-V, and anti-B23 (lanes 3-22 
5) antibodies was examined by PCR using a primer set specific for the Ad VA gene.  23 
(B) B23 associates with entire Ad genome in infected cells.  Immunoprecipitated 24 
DNA with anti-B23 as described in (A) was subjected to quantitative PCR using 25 
 26 
primer sets specific for Ad genome.  Positions of primer sets used are schematically 1 
represented at the bottom of the panel.  Arrows indicate the positions and direction of 2 
the transcription of each gene.  DNA extracted from input extracts was used as 3 
standards to quantify the amount of DNA immunoprecipitated with anti-B23 antibody.  4 
(C-E) ChIP assay of Ad-infected HeLa cells treated with siRNAs.  Control or B23.1 5 
siRNA-treated HeLa cells were infected with Ad, and ChIP assays were carried out 6 
with anti-core protein V, anti-pVII, anti-histone H3 antibodies (C-E, respectively).  7 
Immunoprecipitated DNA was quantitatively examined by q-PCR using primer sets 8 
shown in (B).  Black and white bars in graphs indicate the results obtained from 9 
extracts prepared from control and B23.1 siRNA-treated HeLa cells, respectively.  10 
The amounts of immunoprecipitated DNA were quantitatively analyzed compared 11 
with those of DNAs extracted from input extracts.  For B-E, PCR reaction was carried 12 
out in triplicate, and error bars indicate SD.  Two independent experiments showed 13 
similar results.   14 
 15 
FIG. 5.  Over-expression of exogenous B23.1 counteracts the effect of B23.1 KD 16 
on viral chromatin structure.  (A) The expression levels of endogenous and 17 
exogenous B23.1.  HeLa cells were treated with control- or B23.1-siRNA (lanes 1, 3, 18 
and 5 or 2, 4, and 6) without or with transfection of pCHA (lanes 3 and 4) or pCHA-19 
B23.1 (lanes 5 and 6), and then infected with Ad.  The expression level of B23 and β-20 
actin was examined by western blotting analyses.  (B-D) ChIP assays.  HeLa cells 21 
prepared as described in (A) were subjected to ChIP assays with anti-core protein V 22 
(B), -core protein VII (C), or histone H3 (D) antibody.  Immunoprecipitated DNA 23 
was quantitatively examined by q-PCR using primer sets specific for the Ad VA gene 24 
region.  Black and white bars in graphs indicate the results obtained from extracts 25 
 27 
prepared from control and B23.1 siRNA-treated HeLa cells, respectively.  The 1 
amount of immunoprecipitated DNA was quantitatively analyzed compared with 2 
those of DNAs extracted from input extracts.  PCR reactions were carried out in 3 
triplicate, and error bars indicate SD.   4 
 5 





